Amgen Stock Price Target and Analyst Ratings (NASDAQ:AMGN)

Analyst Price Target for AMGN

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

^$256.09

▲ +11.35% Upside Potential

This price target is based on 25 analysts offering 12 month price targets for Amgen in the last 3 months. The average price target is $256.09, with a high forecast of $304.00 and a low forecast of $215.00. The average price target represents a 11.35% upside from the last price of $229.99.

Buy

The current consensus among 25 polled investment analysts is to buy stock in Amgen. This rating has held steady since April 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
10 buy ratings
8 hold ratings
0 sell ratings

Ratings as of

9/3/2019

0 strong buy ratings
12 buy ratings
9 hold ratings
0 sell ratings

Ratings as of

12/2/2019

0 strong buy ratings
14 buy ratings
10 hold ratings
1 sell ratings

Ratings as of

3/1/2020

0 strong buy ratings
15 buy ratings
12 hold ratings
1 sell ratings

Ratings as of

5/30/2020

0 strong buy ratings
15 buy ratings
12 hold ratings
1 sell ratings

Ratings as of

8/28/2020

0 strong buy ratings
15 buy ratings
12 hold ratings
1 sell ratings

Ratings as of

11/26/2020

0 strong buy ratings
16 buy ratings
11 hold ratings
1 sell ratings

Ratings as of

1/25/2021

0 strong buy ratings
14 buy ratings
11 hold ratings
0 sell ratings

Ratings as of

2/24/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
2/3/2021	Morgan Stanley	Lower Price Target	Overweight	$285.00 ➝ $277.00	Medium	i
2/3/2021	Credit Suisse Group	Lower Price Target	Outperform	$280.00 ➝ $265.00	Medium	i
2/3/2021	SVB Leerink	Lower Price Target	Market Perform	$253.00 ➝ $245.00	Medium	i
2/3/2021	Piper Sandler	Lower Price Target	Overweight	$280.00 ➝ $260.00	Medium	i
2/3/2021	Cantor Fitzgerald	Boost Price Target	Positive ➝ Overweight	$280.00 ➝ $295.00	Low	i
1/31/2021	Oppenheimer	Reiterated Rating	Buy	$266.00	Low	i Rating by Jay Olson at Oppenheimer Holdings Inc.
1/19/2021	Morgan Stanley	Boost Price Target	Overweight	$276.00 ➝ $285.00	Low	i
1/4/2021	Royal Bank of Canada	Reiterated Rating	Neutral		N/A	i
12/29/2020	Daiwa Capital Markets	Initiated Coverage	Buy	$300.00 ➝ $300.00	N/A	i
12/29/2020	Royal Bank of Canada	Reiterated Rating	Neutral		N/A	i
12/27/2020	Oppenheimer	Initiated Coverage	Positive ➝ Buy	$274.00 ➝ $266.00	N/A	i Rating by Jay Olson at Oppenheimer Holdings Inc.
12/27/2020	JPMorgan Chase & Co.	Reiterated Rating	Hold		N/A	i
12/23/2020	Royal Bank of Canada	Reiterated Rating	Neutral		N/A	i
12/16/2020	Morgan Stanley	Boost Price Target	Overweight	$275.00 ➝ $276.00	Low	i
12/15/2020	The Goldman Sachs Group	Downgrade	Conviction-Buy ➝ Buy		Medium	i
12/9/2020	SVB Leerink	Boost Price Target	Market Perform	$243.00 ➝ $253.00	Low	i
12/8/2020	Piper Sandler	Boost Price Target	Overweight	$270.00 ➝ $280.00	Low	i
11/16/2020	Oppenheimer	Lower Price Target	Outperform	$280.00 ➝ $274.00	Low	i Rating by Jay Olson at Oppenheimer Holdings Inc.
11/11/2020	Oppenheimer	Initiated Coverage	Positive ➝ Buy	$275.00 ➝ $280.00	Low	i Rating by Jay Olson at Oppenheimer Holdings Inc.
11/2/2020	Mizuho	Lower Price Target	Neutral	$260.00 ➝ $215.00	Low	i
10/29/2020	Cantor Fitzgerald	Lower Price Target	Overweight	$279.00 ➝ $278.00	Low	i
10/29/2020	BMO Capital Markets	Lower Price Target	Outperform	$308.00 ➝ $304.00	Low	i
10/29/2020	JPMorgan Chase & Co.	Lower Price Target	Neutral	$232.00 ➝ $222.00	Medium	i
10/29/2020	SVB Leerink	Lower Price Target	Market Perform	$261.00 ➝ $243.00	Medium	i
10/29/2020	Bank of America	Lower Price Target	Buy	$275.00 ➝ $265.00	Medium	i
10/29/2020	Morgan Stanley	Boost Price Target	Market Perform ➝ Overweight	$273.00 ➝ $275.00	Medium	i
10/29/2020	Barclays	Lower Price Target	Equal Weight	$250.00 ➝ $242.00	Low	i
10/28/2020	UBS Group	Initiated Coverage	Neutral	$232.00	High	i
10/27/2020	Credit Suisse Group	Lower Price Target	Outperform	$286.00 ➝ $284.00	Low	i
10/26/2020	Raymond James	Upgrade	Market Perform ➝ Outperform	$255.00	Medium	i
10/22/2020	Oppenheimer	Lower Price Target	Outperform	$280.00 ➝ $275.00	Low	i Rating by Jay Olson at Oppenheimer Holdings Inc.
10/15/2020	Royal Bank of Canada	Reiterated Rating	Hold	$223.00	Medium	i
10/13/2020	Morgan Stanley	Lower Price Target	Overweight	$281.00 ➝ $273.00	Low	i
10/12/2020	Truist	Upgrade	Hold ➝ Buy		Low	i
10/9/2020	Truist	Downgrade	Buy ➝ Hold	$251.00	Medium	i
10/9/2020	Sanford C. Bernstein	Downgrade	Outperform ➝ Market Perform		Medium	i
10/6/2020	Raymond James	Reiterated Rating	Outperform ➝ Market Perform		Medium	i
10/6/2020	Oppenheimer	Boost Price Target	Positive ➝ Outperform	$270.00 ➝ $280.00	Medium	i Rating by Jay Olson at Oppenheimer Holdings Inc.
9/23/2020	William Blair	Reiterated Rating	Hold		Medium	i
9/22/2020	JPMorgan Chase & Co.	Reiterated Rating	Hold		High	i
9/21/2020	Oppenheimer	Reiterated Rating	Buy	$270.00	Medium	i Rating by Jay Olson at Oppenheimer Holdings Inc.
7/30/2020	SunTrust Banks	Boost Price Target	Buy	$254.00 ➝ $268.00	Low	i
7/29/2020	Credit Suisse Group	Reiterated Rating	Buy		Low	i
7/29/2020	Wells Fargo & Company	Boost Price Target	Equal Weight ➝ In-Line	$237.00 ➝ $247.00	Low	i
7/29/2020	Jefferies Financial Group	Boost Price Target	Buy	$285.00 ➝ $300.00	Low	i
7/29/2020	Royal Bank of Canada	Lower Price Target	Sector Perform	$236.00 ➝ $223.00	High	i
7/29/2020	Morgan Stanley	Lower Price Target	Overweight	$285.00 ➝ $281.00	Medium	i
7/29/2020	SVB Leerink	Boost Price Target	Market Perform	$253.00 ➝ $261.00	Medium	i
7/29/2020	Cantor Fitzgerald	Boost Price Target	Overweight	$263.00 ➝ $279.00	Medium	i
7/29/2020	Barclays	Boost Price Target	Equal Weight	$245.00 ➝ $250.00	Medium	i
7/28/2020	Piper Sandler	Boost Price Target	Positive ➝ Overweight	$255.00 ➝ $270.00	Medium	i
7/28/2020	JPMorgan Chase & Co.	Boost Price Target	Neutral	$225.00 ➝ $232.00	Medium	i
7/20/2020	Oppenheimer	Boost Price Target	Outperform	$252.00 ➝ $265.00	Low	i Rating by Jay Olson at Oppenheimer Holdings Inc.
7/20/2020	Credit Suisse Group	Boost Price Target	Outperform	$252.00 ➝ $290.00	Low	i
7/15/2020	Morgan Stanley	Boost Price Target	Overweight	$280.00 ➝ $285.00	Low	i
6/18/2020	JPMorgan Chase & Co.	Boost Price Target	Neutral	$219.00 ➝ $225.00	Medium	i
6/2/2020	SVB Leerink	Boost Price Target	Market Perform	$249.00 ➝ $253.00	High	i
5/4/2020	Cantor Fitzgerald	Boost Price Target	Overweight	$255.00 ➝ $263.00	Low	i Rating by Alethia Young at Cantor Fitzgerald
5/1/2020	Cfra	Boost Price Target	Buy	$223.00 ➝ $259.00	Low	i
5/1/2020	Bank of America	Boost Price Target	Buy	$250.00 ➝ $265.00	High	i
5/1/2020	SVB Leerink	Boost Price Target	Market Perform	$219.00 ➝ $249.00	High	i
5/1/2020	Morgan Stanley	Boost Price Target	Overweight	$267.00 ➝ $280.00	High	i Rating by Matthew Harrison at Morgan Stanley
5/1/2020	BMO Capital Markets	Boost Price Target	Positive ➝ Outperform	$274.00 ➝ $291.00	High	i
5/1/2020	Wells Fargo & Company	Boost Price Target	Equal Weight	$220.00 ➝ $237.00	High	i
5/1/2020	Oppenheimer	Initiated Coverage	Buy	$252.00	Medium	i Rating by Jay Olson at Oppenheimer Holdings Inc.
4/30/2020	Mizuho	Reiterated Rating	Hold	$215.00	Medium	i Rating by Salim Syed at Mizuho
4/30/2020	Piper Sandler	Boost Price Target	Overweight	$235.00 ➝ $255.00	Medium	i
4/26/2020	Oppenheimer	Boost Price Target	Outperform	$240.00 ➝ $250.00	Medium	i
4/15/2020	Morgan Stanley	Lower Price Target	Overweight	$277.00 ➝ $267.00	Low	i Rating by Matthew Harrison at Morgan Stanley
4/15/2020	Guggenheim	Initiated Coverage	Neutral	$225.00	Low	i
3/31/2020	Wolfe Research	Initiated Coverage	Market Perform	$218.00	Medium	i
3/29/2020	Raymond James	Upgrade	Market Perform ➝ Outperform	$255.00	High	i Rating by Dane Leone at Raymond James
3/26/2020	Oppenheimer	Lower Price Target	Outperform	$250.00 ➝ $240.00	High	i
3/13/2020	Cfra	Upgrade	Hold ➝ Buy		High	i
3/9/2020	Oppenheimer	Lower Price Target		$256.00 ➝ $250.00	Medium	i Rating by Jason Helfstein at Oppenheimer Holdings Inc.
3/5/2020	Bank of America	Upgrade	Neutral ➝ Buy	$245.00 ➝ $250.00	Medium	i
2/27/2020	Barclays	Initiated Coverage	Equal Weight	$235.00	High	i
2/6/2020	Argus	Reiterated Rating	Buy	$265.00 ➝ $265.00	Low	i
2/3/2020	SunTrust Banks	Boost Price Target	Buy ➝ Buy	$254.00 ➝ $265.00	Low	i
2/2/2020	Credit Suisse Group	Reiterated Rating	Buy	$252.00	Low	i Rating by Evan Seigerman at Credit Suisse Group AG
2/2/2020	JPMorgan Chase & Co.	Reiterated Rating	Neutral ➝ Hold		Low	i Rating by Cory Kasimov at JPMorgan Chase & Co.
1/31/2020	Cfra	Boost Price Target	Hold	$215.00 ➝ $223.00	High	i
1/31/2020	Cowen	Reiterated Rating	Buy		High	i Rating by Yaron Werber at Cowen Inc
1/31/2020	Robert W. Baird	Downgrade	Neutral ➝ Underperform	$173.00 ➝ $185.00	High	i
1/30/2020	Mizuho	Reiterated Rating	Hold	$215.00	High	i Rating by Salim Syed at Mizuho
1/24/2020	JPMorgan Chase & Co.	Set Price Target	Neutral	$198.00	Low	i Rating by Cory Kasimov at JPMorgan Chase & Co.
1/23/2020	Citigroup	Boost Price Target	Buy ➝ In-Line	$245.00 ➝ $275.00	Low	i Rating by Mohit Bansal at Citigroup Inc.
1/22/2020	UBS Group	Boost Price Target	Neutral	$194.00 ➝ $238.00	Low	i
1/21/2020	Oppenheimer	Boost Price Target		$250.00 ➝ $260.00	Low	i Rating by Jason Helfstein at Oppenheimer Holdings Inc.
1/21/2020	Evercore ISI	Upgrade	In-Line ➝ Outperform		Medium	i Rating by Umer Raffat at Evercore ISI
1/19/2020	JPMorgan Chase & Co.	Reiterated Rating	Hold		Medium	i Rating by Cory Kasimov at JPMorgan Chase & Co.
1/17/2020	Morgan Stanley	Lower Price Target	Overweight	$280.00 ➝ $277.00	Low	i Rating by Matthew Harrison at Morgan Stanley
1/14/2020	Cantor Fitzgerald	Reiterated Rating	Buy	$255.00	Low	i Rating by Alethia Young at Cantor Fitzgerald
1/9/2020	BMO Capital Markets	Boost Price Target	Outperform	$240.00 ➝ $275.00	Low	i Rating by Do Kim at BMO Capital Markets
12/23/2019	Raymond James	Initiated Coverage	Market Perform		N/A	i Rating by Dane Leone at Raymond James
12/19/2019	Cowen	Boost Price Target	Outperform	$253.00 ➝ $277.00	Medium	i Rating by Yaron Werber at Cowen Inc
12/17/2019	Morgan Stanley	Initiated Coverage	Overweight	$280.00	Low	i Rating by Matthew Harrison at Morgan Stanley
12/13/2019	Credit Suisse Group	Boost Price Target	Outperform	$235.00 ➝ $250.00	Medium	i Rating by Evan Seigerman at Credit Suisse Group AG
12/9/2019	Argus	Boost Price Target	Positive ➝ Buy	$240.00 ➝ $265.00	Low	i
11/12/2019	SunTrust Banks	Initiated Coverage	Buy	$256.00	Low	i
11/5/2019	Cantor Fitzgerald	Upgrade	Neutral ➝ Overweight	$230.00 ➝ $255.00	Low	i Rating by Alethia Young at Cantor Fitzgerald
10/30/2019	SVB Leerink	Boost Price Target	Market Perform	$189.00 ➝ $205.00	High	i Rating by Geoff Porges at SVB Leerink LLC
10/16/2019	Bank of America	Initiated Coverage	Neutral	$215.00	Low	i
10/14/2019	Sanford C. Bernstein	Initiated Coverage	Outperform		Low	i
9/30/2019	JPMorgan Chase & Co.	Reiterated Rating	Hold		Medium	i Rating by Cory Kasimov at JPMorgan Chase & Co.
9/30/2019	The Goldman Sachs Group	Set Price Target	Buy	$243.00	Medium	i Rating by Terence Flynn at The Goldman Sachs Group, Inc.
9/30/2019	BMO Capital Markets	Set Price Target	Buy	$240.00	Medium	i Rating by Do Kim at BMO Capital Markets
9/30/2019	Cantor Fitzgerald	Set Price Target	Hold	$230.00	Medium	i Rating by Alethia Young at Cantor Fitzgerald
9/30/2019	SVB Leerink	Set Price Target	Hold	$189.00	Medium	i Rating by Geoff Porges at SVB Leerink LLC
9/30/2019	Royal Bank of Canada	Reiterated Rating	Hold		Medium	i Rating by Kennen MacKay at Royal Bank of Canada
9/29/2019	Cowen	Set Price Target	Buy	$231.00	Medium	i Rating by Yaron Werber at Cowen Inc
9/29/2019	Mizuho	Reiterated Rating	Hold	$212.00	Medium	i Rating by Salim Syed at Mizuho
9/12/2019	SVB Leerink	Reiterated Rating	Hold		Low	i Rating by Geoff Porges at SVB Leerink LLC
9/9/2019	BMO Capital Markets	Reiterated Rating	Buy		High	i Rating by Do Kim at BMO Capital Markets
9/9/2019	Oppenheimer	Set Price Target	Buy	$240.00	High	i Rating by Jason Helfstein at Oppenheimer Holdings Inc.
9/6/2019	JPMorgan Chase & Co.	Set Price Target	Hold	$198.00	High	i Rating by Cory Kasimov at JPMorgan Chase & Co.
9/5/2019	Cantor Fitzgerald	Reiterated Rating	Neutral	$221.00 ➝ $230.00	Low	i
8/30/2019	William Blair	Reiterated Rating	Hold		Medium	i
8/29/2019	JPMorgan Chase & Co.	Boost Price Target	Neutral	$191.00 ➝ $198.00	Low	i Rating by Cory Kasimov at JPMorgan Chase & Co.
8/27/2019	Oppenheimer	Boost Price Target		$230.00 ➝ $240.00	Low	i Rating by Jay Olson at Oppenheimer Holdings Inc.
8/27/2019	BMO Capital Markets	Boost Price Target	Outperform	$230.00 ➝ $240.00	Low	i Rating by Do Kim at BMO Capital Markets
8/27/2019	JPMorgan Chase & Co.	Reiterated Rating	Hold	$191.00 ➝ $198.00	Low	i Rating by Cory Kasimov at JPMorgan Chase & Co.
8/27/2019	Wells Fargo & Company	Reiterated Rating	Market Perform	$202.00 ➝ $220.00	Low	i Rating by Jim Birchenough at Wells Fargo & Company
8/27/2019	Royal Bank of Canada	Boost Price Target	Sector Perform	$192.00 ➝ $206.00	Low	i Rating by Kennen MacKay at Royal Bank of Canada
8/26/2019	Piper Jaffray Companies	Boost Price Target	Overweight	$210.00 ➝ $218.00	Low	i Rating by Christopher Raymond at Piper Jaffray Companies
8/22/2019	Cowen	Set Price Target	Buy	$231.00	Low	i Rating by Yaron Werber at Cowen Inc
8/21/2019	Royal Bank of Canada	Boost Price Target	Sector Perform	$192.00	Low	i Rating by Kennen MacKay at Royal Bank of Canada
8/19/2019	Mizuho	Downgrade	Buy ➝ Neutral	$208.00 ➝ $212.00	Low	i Rating by Salim Syed at Mizuho
8/16/2019	Credit Suisse Group	Reiterated Rating	Outperform	$202.00 ➝ $225.00	Low	i Rating by Evan Seigerman at Credit Suisse Group AG
8/13/2019	Oppenheimer	Boost Price Target	Outperform	$210.00 ➝ $230.00	Medium	i Rating by Jay Olson at Oppenheimer Holdings Inc.
8/12/2019	Citigroup	Reiterated Rating	Buy		Low	i Rating by Mohit Bansal at Citigroup Inc.
8/12/2019	Credit Suisse Group	Set Price Target	Buy	$202.00	Low	i Rating by Evan Seigerman at Credit Suisse Group AG
8/12/2019	Wells Fargo & Company	Boost Price Target	Market Perform ➝ Market Perform	$197.00 ➝ $202.00	High	i
8/11/2019	Evercore ISI	Reiterated Rating	Hold		High	i
8/11/2019	Royal Bank of Canada	Reiterated Rating	Hold		High	i
8/10/2019	Piper Jaffray Companies	Set Price Target	Buy	$210.00	Low	i Rating by Christopher Raymond at Piper Jaffray Companies
8/9/2019	JPMorgan Chase & Co.	Reiterated Rating	Hold		Low	i Rating by Cory Kasimov at JPMorgan Chase & Co.
7/31/2019	BMO Capital Markets	Set Price Target	Buy	$230.00	Low	i Rating by Do Kim at BMO Capital Markets
7/15/2019	Morgan Stanley	Lower Price Target	Overweight	$211.00 ➝ $207.00	Low	i
7/1/2019	Mizuho	Reiterated Rating	Buy	$208.00	Low	i Rating by Salim Syed at Mizuho
6/24/2019	Mizuho	Reiterated Rating	Buy	$208.00	Low	i Rating by Salim Syed at Mizuho
5/24/2019	Oppenheimer	Set Price Target	Buy	$210.00	Medium	i Rating by Jay Olson at Oppenheimer Holdings Inc.
5/22/2019	Citigroup	Upgrade	Neutral ➝ Buy	$211.00 ➝ $205.00	Low	i
5/21/2019	Royal Bank of Canada	Reiterated Rating	Neutral	$192.00	Low	i
5/20/2019	Credit Suisse Group	Initiated Coverage	Outperform	$208.00 ➝ $208.00	Low	i
5/17/2019	Mizuho	Reiterated Rating	Buy	$208.00	Low	i Rating by Salim Syed at Mizuho
5/15/2019	JPMorgan Chase & Co.	Reiterated Rating	Hold	$190.00	Medium	i Rating by Cory Kasimov at JPMorgan Chase & Co.
5/10/2019	Mizuho	Set Price Target	Buy	$208.00	High	i Rating by Salim Syed at Mizuho
5/1/2019	Cowen	Reiterated Rating	Buy	$229.00	High	i
4/22/2019	Mizuho	Set Price Target	Buy	$208.00	Low	i Rating by Salim Syed at Mizuho
4/12/2019	Mizuho	Set Price Target	Buy	$208.00	Low	i Rating by Salim Syed at Mizuho
4/1/2019	Cantor Fitzgerald	Reiterated Rating	Hold	$221.00	Low	i Rating by A. Young at Cantor Fitzgerald
3/22/2019	Mizuho	Set Price Target	Buy	$208.00	Low	i Rating by Salim Syed at Mizuho
3/14/2019	BMO Capital Markets	Initiated Coverage	Outperform	$228.00	High	i
2/26/2019	Mizuho	Reiterated Rating	Buy	$211.00	Low	i Rating by Salim Syed at Mizuho
2/26/2019	Cowen	Reiterated Rating	Buy	$234.00	Low	i
2/13/2019	Mizuho	Reiterated Rating	Buy	$211.00	Low	i Rating by Salim Syed at Mizuho
2/1/2019	Royal Bank of Canada	Reiterated Rating	Neutral		Low	i
1/30/2019	SVB Leerink	Lower Price Target	Market Perform	$200.00 ➝ $192.00	High	i Rating by Geoff Porges at SVB Leerink LLC
1/30/2019	JPMorgan Chase & Co.	Reiterated Rating	Neutral	$190.00	High	i Rating by Cory Kasimov at JPMorgan Chase & Co.
1/27/2019	Oppenheimer	Set Price Target	Buy	$224.00	High	i Rating by Jay Olson at Oppenheimer Holdings Inc.
1/17/2019	The Goldman Sachs Group	Reiterated Rating	Buy	$232.00	Low	i
1/14/2019	Royal Bank of Canada	Reiterated Rating	Neutral	$182.00	Low	i
1/4/2019	Citigroup	Boost Price Target	Neutral ➝ Neutral	$204.00 ➝ $210.00	Low	i
12/19/2018	Morgan Stanley	Lower Price Target	Overweight ➝ Overweight	$213.00 ➝ $212.00	Medium	i
12/10/2018	The Goldman Sachs Group	Set Price Target	Buy	$232.00	Low	i
12/4/2018	Jefferies Financial Group	Reiterated Rating	Buy	$220.00	Medium	i
12/4/2018	Barclays	Reiterated Rating	Neutral	$195.00	Medium	i
12/4/2018	Cantor Fitzgerald	Reiterated Rating	Neutral	$223.00	Medium	i Rating by A. Young at Cantor Fitzgerald
12/4/2018	JPMorgan Chase & Co.	Set Price Target	Neutral	$192.00	Medium	i Rating by Cory Kasimov at JPMorgan Chase & Co.
12/4/2018	Royal Bank of Canada	Reiterated Rating	Neutral	$182.00	Medium	i
12/4/2018	Morgan Stanley	Reiterated Rating	Buy	$213.00	Medium	i
12/4/2018	The Goldman Sachs Group	Reiterated Rating	Buy	$232.00	Medium	i
11/1/2018	Royal Bank of Canada	Reiterated Rating	Neutral		Low	i
11/1/2018	Citigroup	Boost Price Target	Neutral ➝ Neutral	$200.00 ➝ $204.00	Low	i
10/31/2018	The Goldman Sachs Group	Reiterated Rating	Buy	$221.00	Low	i
10/31/2018	Morgan Stanley	Boost Price Target	Overweight ➝ Buy	$212.00 ➝ $213.00	Low	i
10/31/2018	Royal Bank of Canada	Lower Price Target	Market Perform	$182.00	Low	i
10/31/2018	Cantor Fitzgerald	Reiterated Rating	Hold	$223.00	Medium	i Rating by A. Young at Cantor Fitzgerald
10/30/2018	Oppenheimer	Set Price Target	Buy	$224.00	Medium	i Rating by Leah R. Cann at Oppenheimer Holdings Inc.
10/26/2018	Mizuho	Reiterated Rating	Buy	$206.00	Low	i Rating by Salim Syed at Mizuho
10/25/2018	JPMorgan Chase & Co.	Reiterated Rating	Neutral		Low	i Rating by Cory Kasimov at JPMorgan Chase & Co.
10/12/2018	The Goldman Sachs Group	Reiterated Rating	Buy	$229.00	Low	i
10/11/2018	Morgan Stanley	Boost Price Target	Overweight	$210.00 ➝ $212.00	Low	i
10/9/2018	JPMorgan Chase & Co.	Set Price Target	Neutral	$192.00	Low	i
10/8/2018	Cantor Fitzgerald	Set Price Target	Neutral	$223.00	Low	i Rating by A. Young at Cantor Fitzgerald
10/8/2018	Jefferies Financial Group	Set Price Target	Buy	$220.00	Low	i
10/2/2018	Oppenheimer	Reiterated Rating	Buy	$224.00	Low	i
10/1/2018	Jefferies Financial Group	Reiterated Rating	Buy	$220.00	Medium	i
10/1/2018	Cantor Fitzgerald	Initiated Coverage	Neutral ➝ Neutral	$223.00	Low	i Rating by A. Young at Cantor Fitzgerald
9/28/2018	Royal Bank of Canada	Set Price Target	Neutral	$193.00	Low	i
9/17/2018	SVB Leerink	Set Price Target	Hold	$209.00	Low	i Rating by Geoff Porges at SVB Leerink LLC
9/12/2018	Jefferies Financial Group	Set Price Target	Buy	$220.00	Low	i
9/10/2018	Oppenheimer	Set Price Target	Buy	$224.00	High	i
9/10/2018	Royal Bank of Canada	Reiterated Rating	Neutral	$193.00	High	i
9/6/2018	Jefferies Financial Group	Set Price Target	Buy	$220.00	Low	i
8/29/2018	Wells Fargo & Company	Reiterated Rating	Neutral	$197.00	Medium	i
8/28/2018	Oppenheimer	Reiterated Rating	Buy	$224.00	Low	i
8/24/2018	Jefferies Financial Group	Reiterated Rating	Buy	$220.00	Low	i
7/30/2018	Morningstar	Set Price Target	Neutral	$198.00	Low	i
7/30/2018	Wells Fargo & Company	Reiterated Rating	Neutral	$197.00	Low	i
7/30/2018	Oppenheimer	Reiterated Rating	Buy	$224.00	Low	i
7/30/2018	Robert W. Baird	Boost Price Target	Neutral ➝ Neutral	$165.00 ➝ $179.00	Low	i
7/30/2018	Citigroup	Boost Price Target	Neutral ➝ Neutral	$188.00 ➝ $200.00	Low	i
7/27/2018	Mizuho	Reiterated Rating	Buy	$200.00	Low	i Rating by Salim Syed at Mizuho
7/27/2018	The Goldman Sachs Group	Reiterated Rating	Buy	$228.00	Low	i
7/27/2018	Royal Bank of Canada	Set Price Target	Buy	$193.00	Low	i
7/27/2018	Jefferies Financial Group	Boost Price Target	Buy ➝ Buy	$200.00 ➝ $220.00	High	i
7/27/2018	JPMorgan Chase & Co.	Boost Price Target	Neutral ➝ Neutral	$191.00 ➝ $192.00	High	i
7/26/2018	Piper Jaffray Companies	Boost Price Target	In-Line ➝ Overweight	$190.00 ➝ $210.00	High	i
7/16/2018	Jefferies Financial Group	Reiterated Rating	Buy	$200.00	Low	i
7/13/2018	Morgan Stanley	Boost Price Target	Buy	$200.00 ➝ $210.00	Low	i
6/22/2018	Mizuho	Reiterated Rating	Buy	$200.00	Low	i Rating by Salim Syed at Mizuho
5/15/2018	Mizuho	Set Price Target	Buy	$200.00	High	i Rating by Salim Syed at Mizuho
4/25/2018	Morgan Stanley	Lower Price Target	Overweight ➝ Overweight	$205.00 ➝ $200.00	Medium	i
4/25/2018	Royal Bank of Canada	Lower Price Target	Sector Perform	$183.00	High	i
4/24/2018	Mizuho	Set Price Target	Buy	$200.00	High	i Rating by Salim Syed at Mizuho
4/24/2018	Cowen	Reiterated Rating	Buy	$204.00	Medium	i
4/5/2018	Barclays	Lower Price Target	Equal Weight ➝ Equal Weight	$190.00 ➝ $180.00	Low	i
2/12/2018	Mizuho	Boost Price Target	Buy ➝ Buy	$192.00 ➝ $200.00	Low	i Rating by Salim Syed at Mizuho
2/5/2018	Atlantic Securities	Downgrade	Overweight ➝ Neutral	$187.01	High	i
2/4/2018	JPMorgan Chase & Co.	Reiterated Rating	Hold	$191.00	High	i
2/2/2018	SVB Leerink	Reiterated Rating	Market Perform		High	i Rating by G. Porges at SVB Leerink LLC
2/2/2018	Cowen	Reiterated Rating	Buy	$204.00	Low	i
2/2/2018	Credit Suisse Group	Boost Price Target	Neutral ➝ Neutral	$191.00 ➝ $194.00	Low	i
2/2/2018	BMO Capital Markets	Boost Price Target	Market Perform ➝ Market Perform	$192.00 ➝ $202.00	Medium	i
2/2/2018	Morgan Stanley	Lower Price Target	Overweight ➝ Overweight	$204.00 ➝ $196.00	Medium	i
2/2/2018	Piper Jaffray Companies	Lower Price Target	Overweight ➝ Overweight	$194.00 ➝ $190.00	Medium	i
2/1/2018	Mizuho	Reiterated Rating	Buy	$192.00	High	i Rating by Salim Syed at Mizuho
1/30/2018	Oppenheimer	Reiterated Rating	Buy	$205.00 ➝ $205.00	Low	i Rating by Leah R. Cann at Oppenheimer Holdings Inc.
1/24/2018	JPMorgan Chase & Co.	Boost Price Target	Neutral ➝ Neutral	$184.00 ➝ $189.00	Low	i
1/24/2018	Royal Bank of Canada	Reiterated Rating	Hold	$189.00	Low	i
1/23/2018	Argus	Upgrade	Hold ➝ Buy	$192.33 ➝ $220.00	Low	i
1/5/2018	Oppenheimer	Set Price Target	Buy	$205.00	Low	i Rating by Leah R. Cann at Oppenheimer Holdings Inc.
1/2/2018	Piper Jaffray Companies	Reiterated Rating	Buy		Low	i
12/28/2017	Mizuho	Set Price Target	Buy	$192.00	Low	i Rating by Salim Syed at Mizuho
12/22/2017	Mizuho	Set Price Target	Buy	$192.00	Low	i Rating by Salim Syed at Mizuho
12/18/2017	Citigroup	Downgrade	Neutral		Low	i
12/15/2017	The Goldman Sachs Group	Downgrade	Conviction-Buy ➝ Buy		High	i
12/12/2017	Oppenheimer	Set Price Target	Buy	$205.00	Low	i Rating by Leah R. Cann at Oppenheimer Holdings Inc.
11/30/2017	Oppenheimer	Reiterated Rating	Buy	$205.00	Low	i Rating by Leah R. Cann at Oppenheimer Holdings Inc.
11/1/2017	Argus	Downgrade	Buy ➝ Hold	$175.22 ➝ $195.00	N/A	i
10/29/2017	Mizuho	Set Price Target	Buy	$198.00	N/A	i Rating by Salim Syed at Mizuho
10/26/2017	BMO Capital Markets	Reiterated Rating	Market Perform	$198.00	N/A	i
10/26/2017	Morgan Stanley	Lower Price Target	Overweight	$196.00 ➝ $193.00	N/A	i
10/26/2017	Royal Bank of Canada	Lower Price Target	Sector Perform	$192.00 ➝ $188.00	N/A	i
10/20/2017	BMO Capital Markets	Reiterated Rating	Hold	$198.00	N/A	i
10/13/2017	Barclays	Boost Price Target	Equal Weight	$180.00 ➝ $190.00	N/A	i
10/6/2017	Oppenheimer	Reiterated Rating	Buy	$203.00	N/A	i Rating by Leah R. Cann at Oppenheimer Holdings Inc.
10/6/2017	Mizuho	Reiterated Rating	Buy	$198.00	N/A	i Rating by Salim Syed at Mizuho
10/6/2017	Morgan Stanley	Reiterated Rating	Overweight	$189.00 ➝ $196.00	N/A	i
10/5/2017	Bank of America	Boost Price Target	Buy	$210.00	N/A	i
9/29/2017	Credit Suisse Group	Reiterated Rating	Neutral	$177.00 ➝ $186.00	Medium	i Rating by Alethia Young at Credit Suisse Group AG
9/28/2017	Mizuho	Reiterated Rating	Buy ➝ Buy	$183.00 ➝ $198.00	Low	i Rating by Salim Syed at Mizuho
9/25/2017	Jefferies Financial Group	Reiterated Rating	Buy	$200.00	Low	i
9/25/2017	BMO Capital Markets	Reiterated Rating	Hold	$199.00	Low	i
9/14/2017	Royal Bank of Canada	Initiated Coverage	Sector Perform ➝ Sector Perform	$192.00	High	i
9/7/2017	Oppenheimer	Reiterated Rating	Buy	$203.00	Low	i Rating by Leah R. Cann at Oppenheimer Holdings Inc.
8/21/2017	Mizuho	Reiterated Rating	Buy	$195.00 ➝ $183.00	Low	i Rating by Salim Syed at Mizuho
7/27/2017	Argus	Boost Price Target	Buy	$180.00 ➝ $195.00	Low	i Rating by Jacob Kilstein at Argus
7/26/2017	UBS Group	Set Price Target	Hold	$175.00 ➝ $180.00	High	i Rating by Carter Gould at UBS Group AG
7/26/2017	Oppenheimer	Reiterated Rating	Outperform	$189.00 ➝ $203.00	Low	i Rating by Leah R. Cann at Oppenheimer Holdings Inc.
7/26/2017	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Hold	$172.00 ➝ $174.00	Low	i Rating by Andrew Peters at Deutsche Bank Aktiengesellschaft
7/26/2017	BMO Capital Markets	Downgrade	Outperform ➝ Market Perform		Low	i
7/22/2017	Cowen	Reiterated Rating	Outperform	$209.00	Low	i
7/21/2017	BMO Capital Markets	Downgrade	Outperform ➝ Market Perform	$199.00	Low	i
7/17/2017	Jefferies Financial Group	Reiterated Rating	Buy	$195.00	Low	i
7/14/2017	Credit Suisse Group	Set Price Target	Hold	$177.00	Low	i Rating by Alethia Young at Credit Suisse Group AG
7/14/2017	Oppenheimer	Reiterated Rating	Outperform	$189.00	Low	i Rating by Leah R. Cann at Oppenheimer Holdings Inc.
7/11/2017	Jefferies Financial Group	Reiterated Rating	Buy ➝ Buy	$195.00	Low	i
7/10/2017	Morgan Stanley	Reiterated Rating	Overweight		Low	i
7/9/2017	Mizuho	Reiterated Rating	Buy	$195.00	Low	i Rating by Salim Syed at Mizuho
6/30/2017	Oppenheimer	Reiterated Rating	Outperform	$189.00	Low	i Rating by Leah R. Cann at Oppenheimer Holdings Inc.
6/26/2017	William Blair	Reiterated Rating	Market Perform		Low	i Rating by M. Phipps at William Blair
6/23/2017	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Hold	$172.00	Medium	i
6/22/2017	SVB Leerink	Reiterated Rating	Market Perform	$161.00	Low	i Rating by Geoff Porges at SVB Leerink LLC
6/13/2017	UBS Group	Reiterated Rating	Neutral	$174.00 ➝ $175.00	N/A	i Rating by Carter Gould at UBS Group AG
6/13/2017	Oppenheimer	Set Price Target	Buy	$189.00	Low	i Rating by Leah R. Cann at Oppenheimer Holdings Inc.
6/13/2017	Morgan Stanley	Boost Price Target	Overweight	$183.00 ➝ $184.00	Low	i
6/8/2017	Sanford C. Bernstein	Set Price Target	Hold	$164.00	Medium	i Rating by Ronny Gal at Sanford C. Bernstein
6/5/2017	Oppenheimer	Set Price Target	Buy	$189.00	Low	i Rating by Leah R. Cann at Oppenheimer Holdings Inc.
5/22/2017	Credit Suisse Group	Set Price Target	Hold	$177.00	Low	i Rating by Alethia Young at Credit Suisse Group AG
5/22/2017	SVB Leerink	Set Price Target	Hold	$159.00	Low	i Rating by Geoff Porges at SVB Leerink LLC
5/22/2017	BMO Capital Markets	Reiterated Rating	Buy	$200.00 ➝ $198.00	Low	i
5/22/2017	UBS Group	Reiterated Rating	Neutral	$175.00 ➝ $174.00	N/A	i Rating by Carter Gould at UBS Group AG
5/22/2017	Jefferies Financial Group	Reiterated Rating	Hold	$180.00	Low	i
5/19/2017	Oppenheimer	Reiterated Rating	Outperform	$189.00	Low	i Rating by Leah R. Cann at Oppenheimer Holdings Inc.
5/9/2017	Oppenheimer	Set Price Target	Buy	$189.00	Low	i Rating by Leah R. Cann at Oppenheimer Holdings Inc.
5/6/2017	Mizuho	Set Price Target	Buy	$195.00	Low	i Rating by Salim Syed at Mizuho
4/28/2017	Robert W. Baird	Reiterated Rating	Neutral	$165.00	Low	i
4/27/2017	Cowen	Reiterated Rating	Buy	$209.00	Low	i
4/25/2017	Sanford C. Bernstein	Reiterated Rating	Market Perform	$178.00	Low	i
4/19/2017	Cowen	Reiterated Rating	Outperform	$209.00	Low	i
4/6/2017	Oppenheimer	Reiterated Rating	Outperform	$189.00	Low	i Rating by Leah R. Cann at Oppenheimer Holdings Inc.
4/5/2017	Jefferies Financial Group	Downgrade	Buy ➝ Hold	$194.00 ➝ $180.00	Low	i
4/4/2017	Credit Suisse Group	Reiterated Rating	Hold	$178.00	Low	i Rating by Alethia Young at Credit Suisse Group AG
4/3/2017	Mizuho	Reiterated Rating	Buy	$195.00	Low	i Rating by Salim Syed at Mizuho
3/20/2017	The Goldman Sachs Group	Lower Price Target	Conviction-Buy	$208.00 ➝ $202.00	Low	i
3/17/2017	Robert W. Baird	Reiterated Rating	Neutral	$165.00	Low	i
3/17/2017	Cowen	Reiterated Rating	Buy	$209.00	Medium	i
3/16/2017	Mizuho	Set Price Target	Buy	$195.00	High	i Rating by Salim Syed at Mizuho
3/14/2017	Oppenheimer	Reiterated Rating	Outperform	$189.00	Low	i Rating by Leah R. Cann at Oppenheimer Holdings Inc.
3/14/2017	Piper Jaffray Companies	Reiterated Rating	Overweight	$193.00	Low	i Rating by joshua schimmer at Piper Jaffray Companies
3/10/2017	Mizuho	Set Price Target	Buy	$195.00	N/A	i
3/9/2017	UBS Group	Initiated Coverage	Neutral ➝ Neutral	$185.00	N/A	i
3/6/2017	Oppenheimer	Set Price Target	Buy	$189.00	N/A	i Rating by Leah R. Cann at Oppenheimer Holdings Inc.
3/6/2017	BMO Capital Markets	Reiterated Rating	Outperform	$212.00	N/A	i
2/28/2017	Oppenheimer	Set Price Target	Buy	$189.00	N/A	i Rating by Leah R. Cann at Oppenheimer Holdings Inc.
2/22/2017	Oppenheimer	Reiterated Rating	Outperform	$175.00	N/A	i Rating by Leah R. Cann at Oppenheimer Holdings Inc.
2/14/2017	Oppenheimer	Set Price Target	Buy	$175.00	N/A	i Rating by Leah R. Cann at Oppenheimer Holdings Inc.
2/13/2017	BMO Capital Markets	Boost Price Target	Outperform	$202.00 ➝ $212.00	N/A	i
2/11/2017	Argus	Set Price Target	Buy	$195.00	N/A	i Rating by Jacob Kilstein at Argus
2/8/2017	Mizuho	Reiterated Rating	Buy		N/A	i
2/5/2017	Credit Suisse Group	Reiterated Rating	Hold	$178.00	N/A	i Rating by Alethia Young at Credit Suisse Group AG
2/3/2017	BMO Capital Markets	Boost Price Target	Positive	$197.00 ➝ $202.00	N/A	i
2/3/2017	Jefferies Financial Group	Reiterated Rating	Buy	$198.00 ➝ $194.00	N/A	i
2/2/2017	Oppenheimer	Set Price Target	Buy	$166.00 ➝ $175.00	N/A	i Rating by Leah R. Cann at Oppenheimer Holdings Inc.
2/1/2017	Bank of America	Upgrade	Neutral ➝ Buy	$156.68 ➝ $192.00	N/A	i
1/31/2017	Royal Bank of Canada	Set Price Target	Buy	$190.00	N/A	i Rating by Michael Yee at Royal Bank of Canada
1/27/2017	Oppenheimer	Set Price Target	Buy	$166.00	N/A	i Rating by Leah R. Cann at Oppenheimer Holdings Inc.
1/10/2017	SVB Leerink	Reiterated Rating	Market Perform		N/A	i Rating by Geoff Porges at SVB Leerink LLC
1/9/2017	BMO Capital Markets	Reiterated Rating	Buy	$197.00	N/A	i
1/8/2017	Robert W. Baird	Reiterated Rating	Neutral	$157.00 ➝ $165.00	N/A	i
1/6/2017	The Goldman Sachs Group	Reiterated Rating	Positive	$202.00 ➝ $218.00	N/A	i
1/4/2017	Royal Bank of Canada	Set Price Target	Buy	$190.00	N/A	i Rating by Michael Yee at Royal Bank of Canada
12/20/2016	Credit Suisse Group	Downgrade	Outperform ➝ Neutral	$200.00 ➝ $180.00	N/A	i Rating by alethia young at Credit Suisse Group AG
12/13/2016	Chardan Capital	Upgrade	Sell ➝ Neutral		N/A	i
12/13/2016	Oppenheimer	Initiated Coverage	Outperform	$166.00 ➝ $166.00	N/A	i
11/21/2016	SVB Leerink	Set Price Target	Hold	$163.00	N/A	i Rating by Geoff Porges at SVB Leerink LLC
11/7/2016	Mizuho	Initiated Coverage	Buy	$164.00	N/A	i
10/30/2016	Royal Bank of Canada	Set Price Target	Buy	$190.00	N/A	i Rating by Michael Yee at Royal Bank of Canada
10/28/2016	SVB Leerink	Reiterated Rating	Market Perform	$193.00 ➝ $163.00	N/A	i Rating by geoff porges at SVB Leerink LLC
9/28/2016	Jefferies Financial Group	Reiterated Rating	Buy		N/A	i Rating by Eun Yang at Jefferies Financial Group Inc.
9/28/2016	Citigroup	Lower Price Target	Neutral	$175.00 ➝ $172.00	N/A	i
9/28/2016	JPMorgan Chase & Co.	Reiterated Rating	Hold		N/A	i
9/27/2016	The Goldman Sachs Group	Reiterated Rating	Buy	$204.00 ➝ $206.00	N/A	i Rating by Terence Flynn at The Goldman Sachs Group, Inc.
9/22/2016	BMO Capital Markets	Reiterated Rating	Outperform	$190.00	N/A	i Rating by Ian Somaiya at BMO Capital Markets
9/20/2016	Jefferies Financial Group	Reiterated Rating	Buy	$198.00	N/A	i Rating by Eun Yang at Jefferies Financial Group Inc.
9/19/2016	Cowen	Reiterated Rating	Buy		N/A	i Rating by Eric Schmidt at Cowen Inc
9/17/2016	SVB Leerink	Reiterated Rating	Hold		N/A	i Rating by geoff porges at SVB Leerink LLC
9/17/2016	Credit Suisse Group	Set Price Target	Buy	$206.00	N/A	i Rating by alethia young at Credit Suisse Group AG
9/15/2016	Piper Jaffray Companies	Set Price Target	Buy	$193.00	N/A	i Rating by joshua schimmer at Piper Jaffray Companies
9/11/2016	SVB Leerink	Reiterated Rating	Hold	$193.00	N/A	i Rating by geoff porges at SVB Leerink LLC
9/8/2016	The Goldman Sachs Group	Reiterated Rating	Buy	$204.00	N/A	i Rating by Terence Flynn at The Goldman Sachs Group, Inc.
8/26/2016	SVB Leerink	Reiterated Rating	Market Perform	$201.00	N/A	i Rating by Geoff Porges at SVB Leerink LLC
8/26/2016	Morgan Stanley	Reiterated Rating	Overweight	$199.00 ➝ $198.00	N/A	i Rating by Matthew Harrison at Morgan Stanley
8/26/2016	Gabelli	Initiated Coverage	Hold		N/A	i Rating by J. He at Gabelli
8/26/2016	Robert W. Baird	Reiterated Rating	Outperform	$157.00	N/A	i Rating by Brian Skorney at Robert W. Baird
8/23/2016	Jefferies Financial Group	Reiterated Rating	Buy	$198.00	N/A	i Rating by Eun Yang at Jefferies Financial Group Inc.
8/5/2016	Argus	Reiterated Rating	Buy	$185.00 ➝ $195.00	N/A	i
8/3/2016	Jefferies Financial Group	Reiterated Rating	Buy		N/A	i Rating by Eun Yang at Jefferies Financial Group Inc.
7/29/2016	Citigroup	Boost Price Target	Neutral	$165.00 ➝ $175.00	N/A	i Rating by Robyn Karnauskas at Citigroup Inc.
7/28/2016	Barclays	Reiterated Rating	Equal Weight	$185.00	N/A	i
7/28/2016	Piper Jaffray Companies	Reiterated Rating	Buy	$193.00	N/A	i Rating by Joshua Schimmer at Piper Jaffray Companies
7/28/2016	Morgan Stanley	Boost Price Target	Overweight	$198.00 ➝ $199.00	N/A	i Rating by Matthew Harrison at Morgan Stanley
7/28/2016	Jefferies Financial Group	Boost Price Target	Buy	$187.00 ➝ $198.00	N/A	i
7/28/2016	Credit Suisse Group	Reiterated Rating	Buy	$206.00	N/A	i Rating by Alethia Young at Credit Suisse Group AG
7/28/2016	SVB Leerink	Reiterated Rating	Market Perform	$186.00 ➝ $201.00	N/A	i Rating by Geoff Porges at SVB Leerink LLC
7/28/2016	BMO Capital Markets	Reiterated Rating	Outperform	$186.00 ➝ $190.00	N/A	i Rating by Ian Somaiya at BMO Capital Markets
7/28/2016	Robert W. Baird	Reiterated Rating	Neutral	$157.00	N/A	i Rating by Brian Skorney at Robert W. Baird
7/15/2016	Robert W. Baird	Reiterated Rating	Neutral	$157.00	N/A	i Rating by Brian Skorney at Robert W. Baird
7/13/2016	Bank of America	Reiterated Rating	Hold	$182.00	N/A	i Rating by Ying Huang at Bank of America Co.
7/13/2016	Jefferies Financial Group	Reiterated Rating	Buy	$187.00	N/A	i
7/12/2016	BMO Capital Markets	Reiterated Rating	Buy	$186.00	N/A	i Rating by Ian Somaiya at BMO Capital Markets
6/29/2016	The Goldman Sachs Group	Reiterated Rating	Buy		N/A	i Rating by Terence Flynn at The Goldman Sachs Group, Inc.
6/29/2016	Morgan Stanley	Reiterated Rating	Overweight		N/A	i Rating by Matthew Harrison at Morgan Stanley
6/29/2016	Sanford C. Bernstein	Initiated Coverage	Market Perform	$161.00	N/A	i
6/26/2016	SVB Leerink	Reiterated Rating	Hold		N/A	i Rating by Geoff Porges at SVB Leerink LLC
6/15/2016	The Goldman Sachs Group	Reiterated Rating	Buy	$202.00	N/A	i
6/9/2016	SVB Leerink	Reiterated Rating	Market Perform	$186.00	N/A	i Rating by Howard Liang at SVB Leerink LLC
6/9/2016	BMO Capital Markets	Reiterated Rating	Outperform	$186.00	N/A	i Rating by Ian Somaiya at BMO Capital Markets
6/8/2016	Bank of America	Reiterated Rating	Hold	$182.00	N/A	i Rating by Ying Huang at Bank of America Co.
5/19/2016	Bank of America	Reiterated Rating	Hold		N/A	i Rating by Ying Huang at Bank of America Co.
5/19/2016	Morgan Stanley	Reiterated Rating	Buy		N/A	i Rating by Matthew Harrison at Morgan Stanley
5/18/2016	Royal Bank of Canada	Reiterated Rating	Buy		N/A	i Rating by Michael Yee at Royal Bank of Canada
5/16/2016	Robert W. Baird	Reiterated Rating	Hold		N/A	i Rating by Brian Skorney at Robert W. Baird
5/10/2016	Piper Jaffray Companies	Reiterated Rating	Buy		N/A	i Rating by Joshua Schimmer at Piper Jaffray Companies
5/1/2016	SVB Leerink	Reiterated Rating	Market Perform	$179.00 ➝ $186.00	N/A	i Rating by Howard Liang at SVB Leerink LLC
4/30/2016	Piper Jaffray Companies	Reiterated Rating	Buy		N/A	i Rating by Joshua Schimmer at Piper Jaffray Companies
4/30/2016	BMO Capital Markets	Reiterated Rating	Buy	$183.00 ➝ $186.00	N/A	i Rating by Ian Somaiya at BMO Capital Markets
4/29/2016	Morgan Stanley	Reiterated Rating	Buy	$195.00	N/A	i Rating by Matthew Harrison at Morgan Stanley
4/17/2016	Cowen	Reiterated Rating	Buy		N/A	i Rating by Eric Schmidt at Cowen Inc
4/8/2016	Morgan Stanley	Boost Price Target		$193.00 ➝ $195.00	N/A	i Rating by Matthew Harrison at Morgan Stanley
4/5/2016	BMO Capital Markets	Initiated Coverage	Outperform	$183.00	N/A	i
4/5/2016	SVB Leerink	Reiterated Rating	Market Perform		N/A	i Rating by Howard Liang at SVB Leerink LLC
3/29/2016	Morgan Stanley	Reiterated Rating	Overweight	$193.00	N/A	i Rating by Matthew Harrison at Morgan Stanley
3/16/2016	Royal Bank of Canada	Reiterated Rating	Buy	$190.00	N/A	i Rating by Michael Yee at Royal Bank of Canada
3/16/2016	Piper Jaffray Companies	Reiterated Rating	Overweight	$191.00	N/A	i Rating by Joshua Schimmer at Piper Jaffray Companies
3/8/2016	Cowen	Reiterated Rating	Outperform	$193.00	N/A	i Rating by Eric Schmidt at Cowen Inc
3/3/2016	Piper Jaffray Companies	Reiterated Rating	Buy	$200.00 ➝ $191.00	N/A	i Rating by Joshua Schimmer at Piper Jaffray Companies
2/25/2016	Citigroup	Initiated Coverage	Neutral	$165.00	N/A	i

(Data available from 2/24/2016 forward)

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, a pegylated protein to treat cancer patients; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Sensipar/Mimpara to treat secondary hyperparathyroidism; and EPOGEN to treat anemia caused by chronic kidney disease. It also markets other products in various markets, including Nplate, Vectibix, Repatha, Parsabiv, BLINCYTO, Aimovig, NEUPOGEN, Otezla, AMGEVITA, KANJINTI, EVENITY, IMLYGIC, MVASI, and Corlanor. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with Novartis; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; QIAGEN N.V.; Adaptive Biotechnologies; and Eli Lilly and Company, as well as has a strategic agreement with McKesson Corporation to help improve cancer care in community oncology settings. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.

Today's Range

Now: $229.99

$227.71

$230.79

50 Day Range

MA: $240.57

$231.47

$258.60

52 Week Range

Now: $229.99

$177.05

$276.69

Volume

2,618,283 shs

Average Volume

2,539,896 shs

Market Capitalization

$132.83 billion

P/E Ratio

18.55

Dividend Yield

3.03%

Beta

0.76

Frequently Asked Questions

What sell-side analysts currently cover shares of Amgen?

The following Wall Street research analysts have issued reports on Amgen in the last year: Bank of America Co., Barclays PLC, BMO Capital Markets, Cantor Fitzgerald, Cfra, Credit Suisse Group AG, Daiwa Capital Markets, Guggenheim, Jefferies Financial Group Inc., JPMorgan Chase & Co., Mizuho, Morgan Stanley, Oppenheimer Holdings Inc., Piper Sandler, Raymond James, Royal Bank of Canada, Sanford C. Bernstein, SunTrust Banks, Inc., SVB Leerink LLC, The Goldman Sachs Group, Inc., Truist, UBS Group AG, Wells Fargo & Company, William Blair, Wolfe Research, and Zacks Investment Research.
View the latest analyst ratings for AMGN.

What is the current price target for Amgen?

22 Wall Street analysts have set twelve-month price targets for Amgen in the last year. Their average twelve-month price target is $256.09, suggesting a possible upside of 11.3%. BMO Capital Markets has the highest price target set, predicting AMGN will reach $304.00 in the next twelve months. Mizuho has the lowest price target set, forecasting a price of $215.00 for Amgen in the next year.
View the latest price targets for AMGN.

What is the current consensus analyst rating for Amgen?

Amgen currently has 11 hold ratings and 14 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe AMGN will outperform the market and that investors should add to their positions of Amgen.
View the latest ratings for AMGN.

What other companies compete with Amgen?

Other companies that are similar to Amgen include Gilead Sciences, Vertex Pharmaceuticals, Regeneron Pharmaceuticals, Biogen, Alexion Pharmaceuticals, Seagen, Exact Sciences, Alnylam Pharmaceuticals, Incyte, Novavax, BioMarin Pharmaceutical, Repligen, Neurocrine Biosciences, Ionis Pharmaceuticals and United Therapeutics.

How do I contact Amgen's investor relations team?

Amgen's physical mailing address is ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA, 91320. The medical research company's listed phone number is 805-447-1000 and its investor relations email address is [email protected] The official website for Amgen is www.amgen.com.

NASDAQ:AMGN - Amgen Stock Price Target and Predictions

Analyst Price Target for AMGN

Past Monthly Recommendations

Latest Recommendations

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Amgen?

What is the current price target for Amgen?

What is the current consensus analyst rating for Amgen?

What other companies compete with Amgen?

How do I contact Amgen's investor relations team?